We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+4.81%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$86.8M
AUM Growth
-$18.6M
Cap. Flow
-$21.3M
Cap. Flow %
-24.54%
Top 10 Hldgs %
34.84%
Holding
103
New
20
Increased
22
Reduced
25
Closed
29

Top Buys

Rank Stock Value
1
ALNA
Allena Pharmaceuticals
ALNA
+$7.09M
2
BIDU icon
Baidu
BIDU
+$2.46M
3
ZBH icon
Zimmer Biomet
ZBH
+$1.67M
4
CME icon
CME Group
CME
+$1.46M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.44M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$2.37M
2
JD icon
JD.com
JD
+$1.84M
3
ELV icon
Elevance Health
ELV
+$1.77M
4
AGN.PRA
Allergan plc
AGN.PRA
+$1.76M
5
CNC icon
Centene
CNC
+$1.61M

Sector Composition

Rank Sector Weight
1 Healthcare 49.46%
2 Technology 16.05%
3 Communication Services 4.89%
4 Financials 3.92%
5 Consumer Discretionary 3.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TREE icon
51
LendingTree
TREE
$464M
$581K 0.67%
1,706
-351
-17% -$99.7K
ANAB icon
52
AnaptysBio
ANAB
$1.6B
$567K 0.65%
+5,628
New +$414K
ICLR icon
53
Icon
ICLR
$12.1B
$557K 0.64%
4,963
-9
-0.2% -$1.04K
MNK
54
PUT
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$553K 0.64%
+24,500
New +$657K
ELGX
55
DELISTED
Endologix Inc
ELGX
$490K 0.56%
9,164
-718
-7% -$37.9K
AMT icon
56
American Tower
AMT
$81.4B
$461K 0.53%
+3,233
New +$462K
HUM icon
57
CALL
Humana
HUM
$43.6B
$447K 0.51%
+1,800
New +$444K
BLUE
58
DELISTED
bluebird bio
BLUE
$350K 0.4%
+152
New +$309K
KURA icon
59
Kura Oncology
KURA
$852M
$284K 0.33%
18,590
-7,127
-28% -$105K
RGNX icon
60
Regenxbio
RGNX
$660M
$279K 0.32%
+8,394
New +$253K
COUP
61
DELISTED
Coupa Software Incorporated
COUP
$278K 0.32%
+8,912
New +$302K
CUTR
62
DELISTED
Cutera, Inc.
CUTR
$192K 0.22%
4,228
-121
-3% -$5.1K
SYNH
63
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$191K 0.22%
+4,388
New +$205K
JNCE
64
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$182K 0.21%
14,265
– –
ARAY icon
65
Accuray
ARAY
$36.2M
$175K 0.2%
40,596
-5,633
-12% -$25.9K
CSII
66
DELISTED
Cardiovascular Systems, Inc.
CSII
$156K 0.18%
6,602
– –
INGN icon
67
Inogen
INGN
$185M
$140K 0.16%
1,175
-2,484
-68% -$274K
NITE
68
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
$132K 0.15%
10,038
+4,688
+88% +$84.3K
LCI
69
PUT
DELISTED
Lannett Company, Inc.
LCI
$118K 0.14%
+1,275
New +$124K
BLK icon
70
Blackrock
BLK
$176B
– –
-1,073
Closed -$480K
CNC icon
71
CALL
Centene
CNC
$31.8B
– –
-26,800
Closed -$1.3M
CNC icon
72
Centene
CNC
$31.8B
– –
-33,336
Closed -$1.61M
EVH icon
73
Evolent Health
EVH
$344M
– –
-33,325
Closed -$593K
GDX icon
74
PUT
VanEck Gold Miners ETF
GDX
$23.9B
– –
-20,700
Closed -$1.93M
INCY icon
75
PUT
Incyte
INCY
$24.3B
– –
-6,600
Closed -$770K
1 2
3
4

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q4 2017 Portfolio in Review

As of Q4 2017, Partner Investment Management held 103 positions worth $86.8M, down 18% from $105M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Partner Investment Management withdrew a net $21.3M in Q4 2017, closing 29 positions and reducing 25 holdings. Its most notable exit was Meta Platforms (Facebook), an estimated $2.37M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, up from 34% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Partner Investment Management opened a new position in Allena Pharmaceuticals worth $4.72M.

  • Partner Investment Management's largest Q4 2017 buy was Allena Pharmaceuticals: 575,407 shares worth $4.72M.
  • Partner Investment Management added most to Puma Biotechnology in Q4 2017, an estimated $568K increase.
  • Partner Investment Management's biggest Q4 2017 reduction was Elevance Health, cutting an estimated $1.77M.
  • Partner Investment Management fully exited Meta Platforms (Facebook) in Q4 2017, selling an estimated $2.37M.
  • Partner Investment Management's ten largest holdings make up 35% of its $86.8M portfolio in Q4 2017.
  • Partner Investment Management opened 20 new positions and closed 29 in Q4 2017.
  • Partner Investment Management's portfolio value fell 18% quarter-over-quarter to $86.8M.

Based on Partner Investment Management's 13F filing for Q4 2017, filed 14 Feb 2018.